Corient Capital Partners’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-153,959	Closed	-$462K	–	767
2022 Q1	$462K	Buy	+153,959	New	+$462K	0.03%	406